← Leaderboards
Michael Stuart Leapman
Yale University
$3,095,744
Attributed
$3,095,744
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $787.6K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,095,744 · 2
By mechanism
R01$1,950,868 · 1
K08$1,144,876 · 1
Top collaborators
No co-investigators on record.
Most similar at Yale University
Same institution · by research overlap
- David L Rimm$13,301,493
- Tarik F Haydar$24,228,248
- E. Jennifer Edelman$16,275,196
- Nicole Holland Weiss$5,381,787
- Nenad Sestan$81,842,296
Others in their field
Other Emerging Leaders on “Affect”
- Chanza Baytop · Westat, Inc.$271,217,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$62,378,387
- Jennifer Marie Suga · Kaiser Foundation Research Institute$29,218,159
- Lynn Briscoe · Leidos Biomedical Research, Inc.$27,788,199
- George Robert Painter · University Of Alabama At Birmingham$27,619,145
- Jessica Brooke Langbaum · Banner Health$22,633,312
Research focus
AffectCostUncertaintyCancer CareImagePhysiciansMalignant Neoplasm Of ProstateInterviewDisease ManagementClinical ManagementRisk AssessmentDecision MakingDiagnosticCharacteristicsHealth Care CostsProviderClinical CareDiagnosisImplementation ScienceAdoptionIndolentControlled StudyHealth SciencesCancer Risk
Grant awards (8)
Optimizing prostate cancer care: integrating risks, benefits, and patient experiences in the new era of molecular imaging$661,782
R01 · FY2025 · CA · contact PI
Optimizing prostate cancer care: integrating risks, benefits, and patient experiences in the new era of molecular imaging$628,694
R01 · FY2024 · CA · contact PI
Optimizing prostate cancer care: integrating risks, benefits, and patient experiences in the new era of molecular imaging$660,392
R01 · FY2023 · CA · contact PI
Understanding the Adoption and Impact of New Risk Assessment Technologies in Prostate Cancer Care$127,208
K08 · FY2023 · CA · contact PI
Understanding the Adoption and Impact of New Risk Assessment Technologies in Prostate Cancer Care$254,417
K08 · FY2022 · CA · contact PI
Understanding the Adoption and Impact of New Risk Assessment Technologies in Prostate Cancer Care$254,417
K08 · FY2021 · CA · contact PI
Understanding the Adoption and Impact of New Risk Assessment Technologies in Prostate Cancer Care$254,417
K08 · FY2020 · CA · contact PI
Understanding the Adoption and Impact of New Risk Assessment Technologies in Prostate Cancer Care$254,417
K08 · FY2019 · CA · contact PI